Klapper LN - Search Results

1

Bivalence of EGF-like ligands drives the ErbB signaling network.

Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y. Tzahar E, et al. Among authors: klapper ln. EMBO J. 1997 Aug 15;16(16):4938-50. doi: 10.1093/emboj/16.16.4938. EMBO J. 1997. PMID: 9305636 Free PMC article.

2

Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M, Yarden Y. Pinkas-Kramarski R, et al. EMBO J. 1996 May 15;15(10):2452-67. EMBO J. 1996. PMID: 8665853 Free PMC article.

3

Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins.

Levkowitz G, Klapper LN, Tzahar E, Freywald A, Sela M, Yarden Y. Levkowitz G, et al. Among authors: klapper ln. Oncogene. 1996 Mar 7;12(5):1117-25. Oncogene. 1996. PMID: 8649804

4

A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors.

Klapper LN, Vaisman N, Hurwitz E, Pinkas-Kramarski R, Yarden Y, Sela M. Klapper LN, et al. Oncogene. 1997 May 1;14(17):2099-109. doi: 10.1038/sj.onc.1201029. Oncogene. 1997. PMID: 9160890

5

The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.

Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y. Pinkas-Kramarski R, et al. Among authors: klapper ln. Oncogene. 1998 Mar 12;16(10):1249-58. doi: 10.1038/sj.onc.1201642. Oncogene. 1998. PMID: 9546426

6

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.

Lenferink AE, Pinkas-Kramarski R, van de Poll ML, van Vugt MJ, Klapper LN, Tzahar E, Waterman H, Sela M, van Zoelen EJ, Yarden Y. Lenferink AE, et al. Among authors: klapper ln. EMBO J. 1998 Jun 15;17(12):3385-97. doi: 10.1093/emboj/17.12.3385. EMBO J. 1998. PMID: 9628875 Free PMC article.

7

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.

Klapper LN, Glathe S, Vaisman N, Hynes NE, Andrews GC, Sela M, Yarden Y. Klapper LN, et al. Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4995-5000. doi: 10.1073/pnas.96.9.4995. Proc Natl Acad Sci U S A. 1999. PMID: 10220407 Free PMC article.

8

Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors.

Klapper LN, Kirschbaum MH, Sela M, Yarden Y. Klapper LN, et al. Adv Cancer Res. 2000;77:25-79. Adv Cancer Res. 2000. PMID: 10549355 Review.

9

Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.

Klapper LN, Waterman H, Sela M, Yarden Y. Klapper LN, et al. Cancer Res. 2000 Jul 1;60(13):3384-8. Cancer Res. 2000. PMID: 10910043

10

c-Cbl is a suppressor of the neu oncogene.

Levkowitz G, Oved S, Klapper LN, Harari D, Lavi S, Sela M, Yarden Y. Levkowitz G, et al. Among authors: klapper ln. J Biol Chem. 2000 Nov 10;275(45):35532-9. doi: 10.1074/jbc.M002661200. J Biol Chem. 2000. PMID: 10940298 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters